StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > GUIDANCE NEEDED

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Feb 20, 2021 7:57pm

108 Views

Post# 32620133

RE:RE:RE:RE:RE:RE:RE:GUIDANCE NEEDED

Hey here's an idea, if you have a comment for management you could, I dunno, email them? Contact Rebecca? All of their information in public. Call me crazy but I could have sworn we already voted for our management, their plans, and the company direction, AND we have multitudinous methods to air our grievances or offer suggestions to management that doesn't include a public chat board that has been proven time, and time again, to be unequivocally used to manipulate the uninitiated.

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta